Orphazyme A/S (ORPHA.CO)

DKK 1120.0

(-2.61%)

Total Debt Summary of Orphazyme A/S

  • Orphazyme A/S's latest annual total debt in 2023 was - DKK , down 0.0% from previous year.
  • Orphazyme A/S's latest quarterly total debt in 2024 Q2 was - DKK , down 0.0% from previous quarter.
  • Orphazyme A/S reported annual total debt of - DKK in 2022, down -100.0% from previous year.
  • Orphazyme A/S reported annual total debt of 39.96 Million DKK in 2021, down -43.48% from previous year.
  • Orphazyme A/S reported quarterly total debt of - DKK for 2024 Q1, down 0.0% from previous quarter.
  • Orphazyme A/S reported quarterly total debt of - DKK for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Orphazyme A/S (2023 - 2013)

Historical Annual Total Debt of Orphazyme A/S (2023 - 2013)

Year Total Debt Total Debt Growth
2023 - DKK 0.0%
2022 - DKK -100.0%
2021 39.96 Million DKK -43.48%
2020 70.71 Million DKK -8.29%
2019 77.1 Million DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK -100.0%
2015 245 Thousand DKK 0.0%
2014 245 Thousand DKK 24400.0%
2013 1000.00 DKK 0.0%

Peer Total Debt Comparison of Orphazyme A/S

Name Total Debt Total Debt Difference
ALK-Abelló A/S 765 Million DKK 100.0%
Bavarian Nordic A/S 145.3 Million DKK 100.0%
Genmab A/S 770 Million DKK 100.0%
Gubra A/S 71.43 Million DKK 100.0%
Novo Nordisk A/S 27 Billion DKK 100.0%
Pharma Equity Group A/S 30.22 Million DKK 100.0%
Zealand Pharma A/S 200.27 Million DKK 100.0%